Zhang, L., Chen, Y., Liu, W., & Wang, K. (2016). Evaluating the clinical significances of serum HE4 with CA125 in peritoneal tuberculosis and epithelial ovarian cancer. Biomarkers, 21(2), 168. https://doi.org/10.3109/1354750X.2015.1118552
Chicago Style (17th ed.) CitationZhang, Lei, Ying Chen, Wenxin Liu, and Ke Wang. "Evaluating the Clinical Significances of Serum HE4 with CA125 in Peritoneal Tuberculosis and Epithelial Ovarian Cancer." Biomarkers 21, no. 2 (2016): 168. https://doi.org/10.3109/1354750X.2015.1118552.
MLA (9th ed.) CitationZhang, Lei, et al. "Evaluating the Clinical Significances of Serum HE4 with CA125 in Peritoneal Tuberculosis and Epithelial Ovarian Cancer." Biomarkers, vol. 21, no. 2, 2016, p. 168, https://doi.org/10.3109/1354750X.2015.1118552.